Beposhell Eye Drop: Bepotastine - Fast and Lasting Relief for Eye Allergies

Dual Mechanism: How Bepotastine Blocks Histamine and Stabilizes Cells

Key Indications: Effective Treatment for Seasonal and Perennial Ocular Itching

Dosage Advantage: Suitable for Twice-Daily Dosing for Patient Comfort

Administration and Safety: The Role of Preservative Benzalkonium Chloride
Exclusive Opportunity: Beposhell Eye Drop PCD Pharma Franchise in Ophthalmology

Home/Products /bepotastine-besilate-15-mg-benzalkonium-chloride-0-005-w-v-eye-drop

Beposhell Eye Drops

Composition : Bepotastine Besilate 15 mg + Benzalkonium Chloride 0.005% w/v Eye Drop

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 5ml

Price : ₹1/-

Beposhell Eye Drop is a highly effective ophthalmic solution containing Bepotastine Besilate 15 mg (1.5%), specifically designed for the treatment of ocular itching associated with allergic conjunctivitis. This medication offers a superior solution for patients suffering from irritating eye allergies.

Mechanism and Impact:Bepotastine acts via a dual mechanism that ensures powerful relief. It is a highly selective H1-receptor antagonist (antihistamine), which rapidly blocks the binding of histamine to its receptors, stopping the immediate feeling of itchiness. Furthermore, it possesses mast cell stabilizing properties, which helps prevent the release of additional inflammatory chemicals, offering sustained relief against common allergy symptoms like redness and burning.

Key Therapeutic Uses:

  • Ocular Itching: Provides rapid reduction of the most common and bothersome symptom of eye allergies.

  • Allergic Conjunctivitis: Effective for managing both acute seasonal allergies and chronic perennial eye allergies.

We offer an exclusive PCD Pharma Franchise opportunity for Beposhell Eye Drop, allowing partners to successfully market a key product in the rapidly growing eye allergy treatment segment.

Read More

About the Product

Beposhell Eye Drop is a highly effective ophthalmic solution containing Bepotastine Besilate 15 mg (1.5%), specifically designed for the treatment of ocular itching associated with allergic conjunctivitis. This medication offers a superior solution for patients suffering from irritating eye allergies.

Mechanism and Impact:Bepotastine acts via a dual mechanism that ensures powerful relief. It is a highly selective H1-receptor antagonist (antihistamine), which rapidly blocks the binding of histamine to its receptors, stopping the immediate feeling of itchiness. Furthermore, it possesses mast cell stabilizing properties, which helps prevent the release of additional inflammatory chemicals, offering sustained relief against common allergy symptoms like redness and burning.

Key Therapeutic Uses:

  • Ocular Itching: Provides rapid reduction of the most common and bothersome symptom of eye allergies.

  • Allergic Conjunctivitis: Effective for managing both acute seasonal allergies and chronic perennial eye allergies.

We offer an exclusive PCD Pharma Franchise opportunity for Beposhell Eye Drop, allowing partners to successfully market a key product in the rapidly growing eye allergy treatment segment.

Common, mild side effects may include brief eye irritation, slight discomfort, or a temporary burning sensation upon application.

Moxolunic BF Eye Drop (BAK Free) Indicated for treating bacterial eye infections, reducing post-surgical pain, redness, and swelling, and alleviating associated itching and discomfort.

Information regarding the use of Moxolunic BF Eye Drop (BAK Free) during breastfeeding is not available. Please consult your doctor.

Store in a cool, dry place at room temperature (15°C to 25°C). Keep the bottle tightly closed and away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation